IBDEI0FE ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20657,0)
 ;;=282.69^^132^1233^37
 ;;^UTILITY(U,$J,358.3,20657,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20657,1,1,0)
 ;;=1^282.69
 ;;^UTILITY(U,$J,358.3,20657,1,8,0)
 ;;=8^Oth Sickle-cell Dis w/ Crisis
 ;;^UTILITY(U,$J,358.3,20657,2)
 ;;=^330081
 ;;^UTILITY(U,$J,358.3,20658,0)
 ;;=282.7^^132^1233^34
 ;;^UTILITY(U,$J,358.3,20658,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20658,1,1,0)
 ;;=1^282.7
 ;;^UTILITY(U,$J,358.3,20658,1,8,0)
 ;;=8^Oth Hemoglobinopathies
 ;;^UTILITY(U,$J,358.3,20658,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,20659,0)
 ;;=282.8^^132^1233^40
 ;;^UTILITY(U,$J,358.3,20659,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20659,1,1,0)
 ;;=1^282.8
 ;;^UTILITY(U,$J,358.3,20659,1,8,0)
 ;;=8^Oth Spec Hereditary Hemolytic
 ;;^UTILITY(U,$J,358.3,20659,2)
 ;;=^267984
 ;;^UTILITY(U,$J,358.3,20660,0)
 ;;=283.10^^132^1233^31
 ;;^UTILITY(U,$J,358.3,20660,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20660,1,1,0)
 ;;=1^283.10
 ;;^UTILITY(U,$J,358.3,20660,1,8,0)
 ;;=8^Non-autoimmune Hemolytic Anemia
 ;;^UTILITY(U,$J,358.3,20660,2)
 ;;=^294004
 ;;^UTILITY(U,$J,358.3,20661,0)
 ;;=283.11^^132^1233^22
 ;;^UTILITY(U,$J,358.3,20661,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20661,1,1,0)
 ;;=1^283.11
 ;;^UTILITY(U,$J,358.3,20661,1,8,0)
 ;;=8^Hemolytic-uremic Syndrome
 ;;^UTILITY(U,$J,358.3,20661,2)
 ;;=^293663
 ;;^UTILITY(U,$J,358.3,20662,0)
 ;;=285.0^^132^1233^52
 ;;^UTILITY(U,$J,358.3,20662,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20662,1,1,0)
 ;;=1^285.0
 ;;^UTILITY(U,$J,358.3,20662,1,8,0)
 ;;=8^Sideroblastic Anemia
 ;;^UTILITY(U,$J,358.3,20662,2)
 ;;=^7204
 ;;^UTILITY(U,$J,358.3,20663,0)
 ;;=285.3^^132^1233^9
 ;;^UTILITY(U,$J,358.3,20663,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20663,1,1,0)
 ;;=1^285.3
 ;;^UTILITY(U,$J,358.3,20663,1,8,0)
 ;;=8^Antineoplastic Chemo Ind Anemia
 ;;^UTILITY(U,$J,358.3,20663,2)
 ;;=^338232
 ;;^UTILITY(U,$J,358.3,20664,0)
 ;;=285.8^^132^1233^39
 ;;^UTILITY(U,$J,358.3,20664,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20664,1,1,0)
 ;;=1^285.8
 ;;^UTILITY(U,$J,358.3,20664,1,8,0)
 ;;=8^Oth Spec Anemia
 ;;^UTILITY(U,$J,358.3,20664,2)
 ;;=^87876
 ;;^UTILITY(U,$J,358.3,20665,0)
 ;;=283.2^^132^1233^21
 ;;^UTILITY(U,$J,358.3,20665,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20665,1,1,0)
 ;;=1^283.2
 ;;^UTILITY(U,$J,358.3,20665,1,8,0)
 ;;=8^Hemolytic d/t Hemolysis
 ;;^UTILITY(U,$J,358.3,20665,2)
 ;;=^55770
 ;;^UTILITY(U,$J,358.3,20666,0)
 ;;=280.0^^132^1233^27
 ;;^UTILITY(U,$J,358.3,20666,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20666,1,1,0)
 ;;=1^280.0
 ;;^UTILITY(U,$J,358.3,20666,1,8,0)
 ;;=8^Iron Def Anemia,d/t Blood Loss Anemia
 ;;^UTILITY(U,$J,358.3,20666,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,20667,0)
 ;;=280.1^^132^1233^28
 ;;^UTILITY(U,$J,358.3,20667,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20667,1,1,0)
 ;;=1^280.1
 ;;^UTILITY(U,$J,358.3,20667,1,8,0)
 ;;=8^Iron Def Anemia,d/t Dietary Intake
 ;;^UTILITY(U,$J,358.3,20667,2)
 ;;=^267972
 ;;^UTILITY(U,$J,358.3,20668,0)
 ;;=280.8^^132^1233^26
 ;;^UTILITY(U,$J,358.3,20668,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20668,1,1,0)
 ;;=1^280.8
 ;;^UTILITY(U,$J,358.3,20668,1,8,0)
 ;;=8^Iron Def Anemia,Oth Spec
 ;;^UTILITY(U,$J,358.3,20668,2)
 ;;=^88088
 ;;^UTILITY(U,$J,358.3,20669,0)
 ;;=284.09^^132^1233^13
 ;;^UTILITY(U,$J,358.3,20669,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20669,1,1,0)
 ;;=1^284.09
 ;;^UTILITY(U,$J,358.3,20669,1,8,0)
 ;;=8^Constitutional Aplastic Anemia,Oth
 ;;^UTILITY(U,$J,358.3,20669,2)
 ;;=^334036
 ;;^UTILITY(U,$J,358.3,20670,0)
 ;;=286.9^^132^1234^9
 ;;^UTILITY(U,$J,358.3,20670,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20670,1,1,0)
 ;;=1^286.9
 ;;^UTILITY(U,$J,358.3,20670,1,8,0)
 ;;=8^Defective Coagulation,Unspec
 ;;^UTILITY(U,$J,358.3,20670,2)
 ;;=^87267
 ;;^UTILITY(U,$J,358.3,20671,0)
 ;;=446.6^^132^1234^26
 ;;^UTILITY(U,$J,358.3,20671,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20671,1,1,0)
 ;;=1^446.6
 ;;^UTILITY(U,$J,358.3,20671,1,8,0)
 ;;=8^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,20671,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,20672,0)
 ;;=451.9^^132^1234^25
 ;;^UTILITY(U,$J,358.3,20672,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20672,1,1,0)
 ;;=1^451.9
 ;;^UTILITY(U,$J,358.3,20672,1,8,0)
 ;;=8^Thrombophlebitis
 ;;^UTILITY(U,$J,358.3,20672,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,20673,0)
 ;;=287.5^^132^1234^23
 ;;^UTILITY(U,$J,358.3,20673,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20673,1,1,0)
 ;;=1^287.5
 ;;^UTILITY(U,$J,358.3,20673,1,8,0)
 ;;=8^Thrombocytopenia Nos
 ;;^UTILITY(U,$J,358.3,20673,2)
 ;;=^118988
 ;;^UTILITY(U,$J,358.3,20674,0)
 ;;=287.30^^132^1234^21
 ;;^UTILITY(U,$J,358.3,20674,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20674,1,1,0)
 ;;=1^287.30
 ;;^UTILITY(U,$J,358.3,20674,1,8,0)
 ;;=8^Primary Thrombocytopenia (ITP)
 ;;^UTILITY(U,$J,358.3,20674,2)
 ;;=^332841
 ;;^UTILITY(U,$J,358.3,20675,0)
 ;;=238.71^^132^1234^24
 ;;^UTILITY(U,$J,358.3,20675,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20675,1,1,0)
 ;;=1^238.71
 ;;^UTILITY(U,$J,358.3,20675,1,8,0)
 ;;=8^Thrombocytosis,Essential
 ;;^UTILITY(U,$J,358.3,20675,2)
 ;;=^334027
 ;;^UTILITY(U,$J,358.3,20676,0)
 ;;=286.53^^132^1234^4
 ;;^UTILITY(U,$J,358.3,20676,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20676,1,1,0)
 ;;=1^286.53
 ;;^UTILITY(U,$J,358.3,20676,1,8,0)
 ;;=8^Antiphospholipid w/ Hemor d/o
 ;;^UTILITY(U,$J,358.3,20676,2)
 ;;=^340503
 ;;^UTILITY(U,$J,358.3,20677,0)
 ;;=286.0^^132^1234^7
 ;;^UTILITY(U,$J,358.3,20677,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20677,1,1,0)
 ;;=1^286.0
 ;;^UTILITY(U,$J,358.3,20677,1,8,0)
 ;;=8^Congenital Factor VII Disorder
 ;;^UTILITY(U,$J,358.3,20677,2)
 ;;=^27454
 ;;^UTILITY(U,$J,358.3,20678,0)
 ;;=286.1^^132^1234^5
 ;;^UTILITY(U,$J,358.3,20678,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20678,1,1,0)
 ;;=1^286.1
 ;;^UTILITY(U,$J,358.3,20678,1,8,0)
 ;;=8^Cogenital Factor IX Disorder
 ;;^UTILITY(U,$J,358.3,20678,2)
 ;;=^27452
 ;;^UTILITY(U,$J,358.3,20679,0)
 ;;=286.2^^132^1234^8
 ;;^UTILITY(U,$J,358.3,20679,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20679,1,1,0)
 ;;=1^286.2
 ;;^UTILITY(U,$J,358.3,20679,1,8,0)
 ;;=8^Congenital Factor XI Deficiency
 ;;^UTILITY(U,$J,358.3,20679,2)
 ;;=^27456
 ;;^UTILITY(U,$J,358.3,20680,0)
 ;;=286.3^^132^1234^6
 ;;^UTILITY(U,$J,358.3,20680,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20680,1,1,0)
 ;;=1^286.3
 ;;^UTILITY(U,$J,358.3,20680,1,8,0)
 ;;=8^Congenital Def of Oth Clotting
 ;;^UTILITY(U,$J,358.3,20680,2)
 ;;=^27437
 ;;^UTILITY(U,$J,358.3,20681,0)
 ;;=286.4^^132^1234^28
 ;;^UTILITY(U,$J,358.3,20681,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20681,1,1,0)
 ;;=1^286.4
 ;;^UTILITY(U,$J,358.3,20681,1,8,0)
 ;;=8^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,20681,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,20682,0)
 ;;=286.52^^132^1234^2
 ;;^UTILITY(U,$J,358.3,20682,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20682,1,1,0)
 ;;=1^286.52
 ;;^UTILITY(U,$J,358.3,20682,1,8,0)
 ;;=8^Acquired Hemophilia
 ;;^UTILITY(U,$J,358.3,20682,2)
 ;;=^340502
 ;;^UTILITY(U,$J,358.3,20683,0)
 ;;=286.59^^132^1234^16
 ;;^UTILITY(U,$J,358.3,20683,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20683,1,1,0)
 ;;=1^286.59
 ;;^UTILITY(U,$J,358.3,20683,1,8,0)
 ;;=8^Oth Hemor d/o d/t Anticoagulant
 ;;^UTILITY(U,$J,358.3,20683,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,20684,0)
 ;;=286.6^^132^1234^10
 ;;^UTILITY(U,$J,358.3,20684,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20684,1,1,0)
 ;;=1^286.6
 ;;^UTILITY(U,$J,358.3,20684,1,8,0)
 ;;=8^Defibrination Syndrome
 ;;^UTILITY(U,$J,358.3,20684,2)
 ;;=^35673
 ;;^UTILITY(U,$J,358.3,20685,0)
 ;;=286.7^^132^1234^1
 ;;^UTILITY(U,$J,358.3,20685,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20685,1,1,0)
 ;;=1^286.7
 ;;^UTILITY(U,$J,358.3,20685,1,8,0)
 ;;=8^Acquired Coagulation Factor Def
 ;;^UTILITY(U,$J,358.3,20685,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,20686,0)
 ;;=287.0^^132^1234^3
 ;;^UTILITY(U,$J,358.3,20686,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20686,1,1,0)
 ;;=1^287.0
 ;;^UTILITY(U,$J,358.3,20686,1,8,0)
 ;;=8^Allergic Purpura
 ;;^UTILITY(U,$J,358.3,20686,2)
 ;;=^101365
 ;;^UTILITY(U,$J,358.3,20687,0)
 ;;=287.1^^132^1234^22
 ;;^UTILITY(U,$J,358.3,20687,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20687,1,1,0)
 ;;=1^287.1
 ;;^UTILITY(U,$J,358.3,20687,1,8,0)
 ;;=8^Qualitative Platelet Defects
 ;;^UTILITY(U,$J,358.3,20687,2)
 ;;=^101922
 ;;^UTILITY(U,$J,358.3,20688,0)
 ;;=287.2^^132^1234^17
 ;;^UTILITY(U,$J,358.3,20688,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20688,1,1,0)
 ;;=1^287.2
 ;;^UTILITY(U,$J,358.3,20688,1,8,0)
 ;;=8^Oth Nonthrombocytopenic Purpuras
 ;;^UTILITY(U,$J,358.3,20688,2)
 ;;=^87741
 ;;^UTILITY(U,$J,358.3,20689,0)
 ;;=287.31^^132^1234^13
 ;;^UTILITY(U,$J,358.3,20689,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20689,1,1,0)
 ;;=1^287.31
 ;;^UTILITY(U,$J,358.3,20689,1,8,0)
 ;;=8^Immune Thrombocytopenic Purpura
 ;;^UTILITY(U,$J,358.3,20689,2)
 ;;=^332746
 ;;^UTILITY(U,$J,358.3,20690,0)
 ;;=287.32^^132^1234^11
 ;;^UTILITY(U,$J,358.3,20690,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20690,1,1,0)
 ;;=1^287.32
 ;;^UTILITY(U,$J,358.3,20690,1,8,0)
 ;;=8^Evan's Syndrome
 ;;^UTILITY(U,$J,358.3,20690,2)
 ;;=^332747
 ;;^UTILITY(U,$J,358.3,20691,0)
 ;;=287.41^^132^1234^20
 ;;^UTILITY(U,$J,358.3,20691,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20691,1,1,0)
 ;;=1^287.41
 ;;^UTILITY(U,$J,358.3,20691,1,8,0)
 ;;=8^Posttransfusion Purpura
 ;;^UTILITY(U,$J,358.3,20691,2)
 ;;=^339609
 ;;^UTILITY(U,$J,358.3,20692,0)
 ;;=287.49^^132^1234^18
 ;;^UTILITY(U,$J,358.3,20692,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20692,1,1,0)
 ;;=1^287.49
 ;;^UTILITY(U,$J,358.3,20692,1,8,0)
 ;;=8^Oth Secondary Thrombocytopenia
 ;;^UTILITY(U,$J,358.3,20692,2)
 ;;=^339610
 ;;^UTILITY(U,$J,358.3,20693,0)
 ;;=287.8^^132^1234^19
 ;;^UTILITY(U,$J,358.3,20693,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20693,1,1,0)
 ;;=1^287.8
